• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转移性阴茎癌的非手术治疗案例。

The case for nonsurgical therapy of nonmetastatic penile cancer.

机构信息

Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.

出版信息

Nat Rev Urol. 2018 Sep;15(9):574-584. doi: 10.1038/s41585-018-0040-y.

DOI:10.1038/s41585-018-0040-y
PMID:29950592
Abstract

Invasive squamous cell carcinoma (SCC) of the penis is almost always treated with surgical therapy at the primary site. However, almost all other SCC primary sites, such as anal, vulvar, uterine cervix, head and neck, and oesophagus, and their involved nodal basins, can be successfully treated with radiotherapy or combined chemotherapy and radiation, reserving surgery as a salvage option. Review of the penile cancer literature and examination of data from more common SCC primary sites make a case for complete organ preservation of the penis using definitive combined chemotherapy and radiation, reserving surgical therapies as salvage options.

摘要

阴茎浸润性鳞状细胞癌 (SCC) 几乎总是在原发部位采用手术治疗。然而,几乎所有其他 SCC 原发部位,如肛门、外阴、子宫颈、头颈部和食管,以及其受累的淋巴结区域,都可以通过放疗或联合化疗和放疗成功治疗,保留手术作为挽救性选择。对阴茎癌文献的回顾和对更常见 SCC 原发部位数据的检查表明,使用确定性联合化疗和放疗完全保留阴茎器官,将手术治疗作为挽救性选择是合理的。

相似文献

1
The case for nonsurgical therapy of nonmetastatic penile cancer.非转移性阴茎癌的非手术治疗案例。
Nat Rev Urol. 2018 Sep;15(9):574-584. doi: 10.1038/s41585-018-0040-y.
2
Definitive Chemoradiotherapy for Locally Advanced, Lymph-node Positive, Nonmetastatic Penile Squamous Cell Carcinoma.局部晚期、淋巴结阳性、无转移的阴茎鳞状细胞癌的确定性放化疗。
Clin Genitourin Cancer. 2020 Oct;18(5):e573-e584. doi: 10.1016/j.clgc.2020.02.007. Epub 2020 Mar 3.
3
A 10-year retrospective audit of penile cancer management in the UK.英国阴茎癌治疗的10年回顾性审计
BJU Int. 2007 Dec;100(6):1277-81. doi: 10.1111/j.1464-410X.2007.07168.x. Epub 2007 Sep 10.
4
Local treatment of penile squamous cell carcinoma.阴茎鳞状细胞癌的局部治疗
Urol Int. 2002;69(3):169-73. doi: 10.1159/000063950.
5
Penile cancer: curable with early detection.阴茎癌:早期发现可治愈。
Hosp Pract (Off Ed). 1991 Jun 15;26(6):131-8. doi: 10.1080/21548331.1991.11704194.
6
EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.内镜黏膜切除术作为食管癌根治性放化疗局部区域失败患者的挽救性治疗方法。
Gastrointest Endosc. 2003 Jul;58(1):65-70. doi: 10.1067/mge.2003.306.
7
EAU penile cancer guidelines 2009.EAU 阴茎癌指南 2009.
Eur Urol. 2010 Jun;57(6):1002-12. doi: 10.1016/j.eururo.2010.01.039. Epub 2010 Feb 4.
8
The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.鳞状细胞癌抗原在阴茎癌患者预后评估、治疗监测及随访中的价值。
J Urol. 2008 Nov;180(5):2019-23. doi: 10.1016/j.juro.2008.07.040. Epub 2008 Sep 17.
9
Carcinoma of the penis. Experience with 153 cases.
Urology. 1973 May;1(5):404-8. doi: 10.1016/0090-4295(73)90368-3.
10
Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes.一线化疗失败后转移性阴茎癌的治疗:反应和生存结果分析
Urology. 2015 May;85(5):1104-1110. doi: 10.1016/j.urology.2014.12.049. Epub 2015 Mar 25.

引用本文的文献

1
The role of radiotherapy in the management of squamous cell cancer of the penis.放疗在阴茎鳞状细胞癌治疗中的作用。
World J Urol. 2023 Dec;41(12):3913-3920. doi: 10.1007/s00345-023-04683-7. Epub 2023 Nov 23.
2
Immune-based therapies in penile cancer.阴茎癌的免疫治疗
Nat Rev Urol. 2022 Aug;19(8):457-474. doi: 10.1038/s41585-022-00617-x. Epub 2022 Jul 18.
3
Understanding genomics and the immune environment of penile cancer to improve therapy.了解阴茎癌的基因组学和免疫环境,以改善治疗效果。
Nat Rev Urol. 2020 Oct;17(10):555-570. doi: 10.1038/s41585-020-0359-z. Epub 2020 Aug 18.